{"success":true,"data":{"pressRelease":{"id":"2898","rtpr_id":"nPn9QgmXFa","ticker":"BSX","exchange":"NYSE","all_tickers":["BSX"],"title":"BSX Shareholder Alert: May 4, 2026 Lead Plaintiff Deadline in Boston Scientific Corporation Securities Class Action Lawsuit -- The Gross Law Firm","author":"PR Newswire","published_at":"2026-04-21T13:00:15.937Z","article_body":"BSX Shareholder Alert: May 4, 2026 Lead Plaintiff Deadline in Boston Scientific Corporation Securities Class Action Lawsuit -- The Gross Law Firm\n\nPR Newswire\n\nNEW YORK, April 21, 2026\n\nNEW YORK, April 21, 2026 /PRNewswire/ -- The Gross Law Firm issues the\nfollowing notice to shareholders of Boston Scientific Corporation (NYSE: BSX).\n\n(https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.html)\n\nShareholders who purchased shares of BSX during the class period listed are\nencouraged to contact the firm regarding possible lead plaintiff appointment.\nAppointment as lead plaintiff is not required to partake in any recovery.\n\nCONTACT US HERE:\n\nhttps://securitiesclasslaw.com/securities/boston-scientific-corporation-loss-submission-form-2/?id=185675&from=4\n(https://securitiesclasslaw.com/securities/boston-scientific-corporation-loss-submission-form-2/?id=185675&from=4)\n\nCLASS PERIOD: July 23, 2025 to February 3, 2026\n\nALLEGATIONS: According to the complaint, defendants provided overwhelmingly\npositive statements to investors while, at the same time, disseminating\nmaterially false and misleading statements and/or concealing material adverse\nfacts concerning the true state of Boston Scientific's U.S. EP segment;\nnotably, that management was aware that the segment's growth rate was\nunsustainable and that it was approaching an earlier tipping point than the\nmarket was anticipating. Due to defendants' statements of confidence and lofty\nexpectations, investors and analysts were left surprised by Boston\nScientific's net income miss and underwhelming guidance for the first half of\nfiscal 2026.  On February 4, 2026, Boston Scientific published a press\nrelease announcing fourth quarter and full year 2025 results, including a\npertinent disappointment in U.S. EP sales, and issued guidance for fiscal 2026\nthat fell well below expectations. The Company attributed its results and\ndismal guidance on a combination of slower than expected market growth\nalongside increased competition, despite management's previous claims of a\n\"growing\" EP business and assertions they \"have a very good understanding of\nwhat competition we will face and in what time frame.\"  Following this news,\nthe price of Boston Scientific's common stock declined dramatically. From a\nclosing market price of $91.62 per share on February 3, 2026, Boston\nScientific's stock price fell to $75.50 per share on February 4, 2026, a\ndecline of about 17.6% in the span of just a single day.\n\nDEADLINE: May 4, 2026 Shareholders should not delay in registering for this\nclass action. Register your information here:\nhttps://securitiesclasslaw.com/securities/boston-scientific-corporation-loss-submission-form-2/?id=185675&from=4\n(https://securitiesclasslaw.com/securities/boston-scientific-corporation-loss-submission-form-2/?id=185675&from=4)\n\nNEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased\nshares of BSX during the timeframe listed above, you will be enrolled in a\nportfolio monitoring software to provide you with status updates throughout\nthe lifecycle of the case. The deadline to seek to be a lead plaintiff is May\n4, 2026. There is no cost or obligation to you to participate in this case.\n\nWHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action\nlaw firm, and our mission is to protect the rights of all investors who have\nsuffered as a result of deceit, fraud, and illegal business practices. The\nGross Law Firm is committed to ensuring that companies adhere to responsible\nbusiness practices and engage in good corporate citizenship. The firm seeks\nrecovery on behalf of investors who incurred losses when false and/or\nmisleading statements or the omission of material information by a company\nlead to artificial inflation of the company's stock. Attorney advertising.\nPrior results do not guarantee similar outcomes.\n\nCONTACT:\nThe Gross Law Firm\n15 West 38th Street, 12th floor\nNew York, NY, 10018\nEmail: dg@securitiesclasslaw.com (mailto:dg@securitiesclasslaw.com)\nPhone: (646) 453-8903\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/bsx-shareholder-alert-may-4-2026-lead-plaintiff-deadline-in-boston-scientific-corporation-securities-class-action-lawsuit--the-gross-law-firm-302748236.html\n(https://www.prnewswire.com/news-releases/bsx-shareholder-alert-may-4-2026-lead-plaintiff-deadline-in-boston-scientific-corporation-securities-class-action-lawsuit--the-gross-law-firm-302748236.html)\n\nSOURCE The Gross Law Firm\n\n\n\nPhoto: \nhttps://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPn9QgmXFa","title":"BSX Shareholder Alert: May 4, 2026 Lead Plaintiff Deadline in Boston Scientific Corporation Securities Class Action Lawsuit -- The Gross Law Firm","author":"PR Newswire","ticker":"BSX","created":"2026-04-21T13:00:15.937Z","tickers":["BSX"],"exchange":"NYSE","article_body":"BSX Shareholder Alert: May 4, 2026 Lead Plaintiff Deadline in Boston Scientific Corporation Securities Class Action Lawsuit -- The Gross Law Firm\n\nPR Newswire\n\nNEW YORK, April 21, 2026\n\nNEW YORK, April 21, 2026 /PRNewswire/ -- The Gross Law Firm issues the\nfollowing notice to shareholders of Boston Scientific Corporation (NYSE: BSX).\n\n(https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.html)\n\nShareholders who purchased shares of BSX during the class period listed are\nencouraged to contact the firm regarding possible lead plaintiff appointment.\nAppointment as lead plaintiff is not required to partake in any recovery.\n\nCONTACT US HERE:\n\nhttps://securitiesclasslaw.com/securities/boston-scientific-corporation-loss-submission-form-2/?id=185675&from=4\n(https://securitiesclasslaw.com/securities/boston-scientific-corporation-loss-submission-form-2/?id=185675&from=4)\n\nCLASS PERIOD: July 23, 2025 to February 3, 2026\n\nALLEGATIONS: According to the complaint, defendants provided overwhelmingly\npositive statements to investors while, at the same time, disseminating\nmaterially false and misleading statements and/or concealing material adverse\nfacts concerning the true state of Boston Scientific's U.S. EP segment;\nnotably, that management was aware that the segment's growth rate was\nunsustainable and that it was approaching an earlier tipping point than the\nmarket was anticipating. Due to defendants' statements of confidence and lofty\nexpectations, investors and analysts were left surprised by Boston\nScientific's net income miss and underwhelming guidance for the first half of\nfiscal 2026.  On February 4, 2026, Boston Scientific published a press\nrelease announcing fourth quarter and full year 2025 results, including a\npertinent disappointment in U.S. EP sales, and issued guidance for fiscal 2026\nthat fell well below expectations. The Company attributed its results and\ndismal guidance on a combination of slower than expected market growth\nalongside increased competition, despite management's previous claims of a\n\"growing\" EP business and assertions they \"have a very good understanding of\nwhat competition we will face and in what time frame.\"  Following this news,\nthe price of Boston Scientific's common stock declined dramatically. From a\nclosing market price of $91.62 per share on February 3, 2026, Boston\nScientific's stock price fell to $75.50 per share on February 4, 2026, a\ndecline of about 17.6% in the span of just a single day.\n\nDEADLINE: May 4, 2026 Shareholders should not delay in registering for this\nclass action. Register your information here:\nhttps://securitiesclasslaw.com/securities/boston-scientific-corporation-loss-submission-form-2/?id=185675&from=4\n(https://securitiesclasslaw.com/securities/boston-scientific-corporation-loss-submission-form-2/?id=185675&from=4)\n\nNEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased\nshares of BSX during the timeframe listed above, you will be enrolled in a\nportfolio monitoring software to provide you with status updates throughout\nthe lifecycle of the case. The deadline to seek to be a lead plaintiff is May\n4, 2026. There is no cost or obligation to you to participate in this case.\n\nWHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action\nlaw firm, and our mission is to protect the rights of all investors who have\nsuffered as a result of deceit, fraud, and illegal business practices. The\nGross Law Firm is committed to ensuring that companies adhere to responsible\nbusiness practices and engage in good corporate citizenship. The firm seeks\nrecovery on behalf of investors who incurred losses when false and/or\nmisleading statements or the omission of material information by a company\nlead to artificial inflation of the company's stock. Attorney advertising.\nPrior results do not guarantee similar outcomes.\n\nCONTACT:\nThe Gross Law Firm\n15 West 38th Street, 12th floor\nNew York, NY, 10018\nEmail: dg@securitiesclasslaw.com (mailto:dg@securitiesclasslaw.com)\nPhone: (646) 453-8903\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/bsx-shareholder-alert-may-4-2026-lead-plaintiff-deadline-in-boston-scientific-corporation-securities-class-action-lawsuit--the-gross-law-firm-302748236.html\n(https://www.prnewswire.com/news-releases/bsx-shareholder-alert-may-4-2026-lead-plaintiff-deadline-in-boston-scientific-corporation-securities-class-action-lawsuit--the-gross-law-firm-302748236.html)\n\nSOURCE The Gross Law Firm\n\n\n\nPhoto: \nhttps://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-04-21T13:00:16.014056777Z","server_sent_at_ms":1776776416014},"received_at":"2026-04-21T13:00:16.069Z","source_url":"https://www.prnewswire.com/news-releases/bsx-shareholder-alert-may-4-2026-lead-plaintiff-deadline-in-boston-scientific-corporation-securities-class-action-lawsuit--the-gross-law-firm-302748236.html"},"analysis":{"id":"1873","press_release_id":"2898","analysis_json":{"industry":{"label":"Health Care Equipment & Services","sector":"Health Care"},"redFlags":["Securities class action lawsuit alleges material misrepresentation regarding business segment growth","Alleged 17.6% single-day stock decline following guidance miss"],"eventType":"legal_litigation","narrative":"The Gross Law Firm announced a lead plaintiff deadline of May 4, 2026, for a class action lawsuit against Boston Scientific.\n\nThe lawsuit alleges the company made false statements about its U.S. EP segment, resulting in a 17.6% stock decline on February 4 following a guidance miss.\n\nShareholders who purchased shares between July 23, 2025, and February 3, 2026, are encouraged to contact the firm.","sentiment":"bearish","agentHooks":{"shouldPost":false,"suggestedAngle":"Class action deadline reminder over alleged guidance miss and 17% stock drop."},"keyFigures":{"customDimensions":{"class_period_end":"February 3, 2026","class_period_start":"July 23, 2025","stock_decline_percent":"17.6%","lead_plaintiff_deadline":"May 4, 2026"}},"namedEntities":{"people":[],"products":[],"companies":[{"name":"Boston Scientific Corporation","ticker":"BSX"},{"name":"The Gross Law Firm","relationship":"plaintiff counsel"}],"dollarAmounts":[{"amount":"$91.62","context":"closing market price on February 3, 2026"},{"amount":"$75.50","context":"closing market price on February 4, 2026"}]},"materialImpact":{"score":3,"reasoning":"Class action lawsuit reminder alleging securities fraud tied to a significant prior stock drop (17.6%) and guidance miss. While the underlying event was material, this is a procedural deadline notice."},"tickerRelevance":{"others":[],"primary":"BSX"},"eventTypeSecondary":[]},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"bearish","material_impact_score":3,"narrative":"The Gross Law Firm announced a lead plaintiff deadline of May 4, 2026, for a class action lawsuit against Boston Scientific.\n\nThe lawsuit alleges the company made false statements about its U.S. EP segment, resulting in a 17.6% stock decline on February 4 following a guidance miss.\n\nShareholders who purchased shares between July 23, 2025, and February 3, 2026, are encouraged to contact the firm.","key_figures":{"customDimensions":{"class_period_end":"February 3, 2026","class_period_start":"July 23, 2025","stock_decline_percent":"17.6%","lead_plaintiff_deadline":"May 4, 2026"}},"named_entities":{"people":[],"products":[],"companies":[{"name":"Boston Scientific Corporation","ticker":"BSX"},{"name":"The Gross Law Firm","relationship":"plaintiff counsel"}],"dollarAmounts":[{"amount":"$91.62","context":"closing market price on February 3, 2026"},{"amount":"$75.50","context":"closing market price on February 4, 2026"}]},"model_name":"glm-4.7","prompt_hash":"sha256:2f2748f0fcc8c4f2","schema_hash":"sha256:ad96b863d7123008","created_at":"2026-04-21T18:15:24.052Z","global_importance":3,"audience_relevance":3,"importance_components":{"method":"backfill-heuristic","signals":{"bodyLong":false,"headlineTier1":false,"tickerCovered":false,"hadSignificance":false},"version":1,"computedAt":"2026-04-27T11:52:53.440Z"}},"durationMs":109536,"modelName":"glm-4.7"}}